{"formats":[{"name":"JSON","format":"json","url":"\/downloads\/2026\/code-json\/32.1-162.5_1.json"},{"name":"Plain Text","format":"text","url":"\/downloads\/2026\/code-text\/32.1-162.5_1.txt"},{"name":"XML","format":"xml","url":"\/downloads\/2026\/code-xml\/32.1-162.5_1.xml"},{"name":"HTML","format":"html","url":"\/downloads\/2026\/code-html\/32.1-162.5_1.html"}],"law_id":359168,"edition_id":2,"section_id":359168,"structure_id":51372,"section_number":"32.1-162.5:1","catch_line":"Notice to dispenser of patient’s death; disposition of dispensed drugs","history":"2015, c. 668; 2018, c. 95; 2020, c. 739.","full_text":"A\n\nAny hospice licensed by the Department or exempt from licensure pursuant to § 32.1-162.2 with a hospice patient residing at home at the time of death shall notify every pharmacy that has dispensed partial quantities of a Schedule II controlled substance for a patient with a medical diagnosis documenting a terminal illness, as authorized by federal law, within 48 hours of the patient’s death.\n\nB\n\nAny hospice licensed by the Department or exempt from licensure pursuant to § 32.1-162.2 shall develop policies and procedures for the disposal of drugs, including opioids, dispensed as part of the hospice plan of care in accordance with the provisions of § 54.1-3411.2.\n\n","order_by":null,"text":{"0":{"id":1336190,"text":"Any hospice licensed by the Department or exempt from licensure pursuant to § 32.1-162.2 with a hospice patient residing at home at the time of death shall notify every pharmacy that has dispensed partial quantities of a Schedule II controlled substance for a patient with a medical diagnosis documenting a terminal illness, as authorized by federal law, within 48 hours of the patient’s death.","type":"section","prefixes":["A"],"prefix":"A","entire_prefix":"A","prefix_anchor":"A","level":1,"next_prefix":"B"},"1":{"id":1336191,"text":"Any hospice licensed by the Department or exempt from licensure pursuant to § 32.1-162.2 shall develop policies and procedures for the disposal of drugs, including opioids, dispensed as part of the hospice plan of care in accordance with the provisions of § 54.1-3411.2.","type":"section","prefixes":["B"],"prefix":"B","entire_prefix":"B","prefix_anchor":"B","level":1,"prior_prefix":"A"}},"ancestry":[{"id":51372,"edition_id":2,"name":"Hospice Program Licensing","identifier":"7","label":"article","depth":3,"order_by":5,"parent_id":51361,"metadata":{"child_laws":8,"child_structures":0},"date_created":"2026-08-02 02:41:23","date_modified":"2026-08-02 12:32:20","permalink":{"id":1430265,"object_type":"structure","relational_id":51372,"identifier":"7","token":"32.1\/5\/7","url":"\/32.1\/5\/7\/","edition_id":2,"permalink":0,"preferred":1}},{"id":51361,"edition_id":2,"name":"Regulation of Medical Care Facilities and Services","identifier":"5","label":"chapter","depth":2,"order_by":5,"parent_id":51343,"metadata":{"child_laws":150,"child_structures":13},"date_created":"2026-08-02 02:41:12","date_modified":"2026-08-02 12:32:20","permalink":{"id":1429857,"object_type":"structure","relational_id":51361,"identifier":"5","token":"32.1\/5","url":"\/32.1\/5\/","edition_id":2,"permalink":0,"preferred":1}},{"id":51343,"edition_id":2,"name":"Health","identifier":"32.1","label":"title","depth":1,"order_by":75,"parent_id":null,"metadata":{"child_laws":857,"child_structures":128},"date_created":"2026-08-02 02:40:53","date_modified":"2026-08-02 12:32:12","permalink":{"id":1428101,"object_type":"structure","relational_id":51343,"identifier":"32.1","token":"32.1","url":"\/32.1\/","edition_id":2,"permalink":0,"preferred":1}}],"structure_contents":[{"id":359104,"structure_id":51372,"section_number":"32.1-162.1","catch_line":"Definitions","url":"\/32.1-162.1\/","token":"32.1\/5\/7\/32.1-162.1","metadata":false},{"id":359150,"structure_id":51372,"section_number":"32.1-162.2","catch_line":"Exemptions from article","url":"\/32.1-162.2\/","token":"32.1\/5\/7\/32.1-162.2","metadata":false},{"id":359161,"structure_id":51372,"section_number":"32.1-162.3","catch_line":"License required for hospice programs; notice of denial of license; renewal thereof","url":"\/32.1-162.3\/","token":"32.1\/5\/7\/32.1-162.3","metadata":{"court_decisions":""}},{"id":359166,"structure_id":51372,"section_number":"32.1-162.4","catch_line":"Inspections","url":"\/32.1-162.4\/","token":"32.1\/5\/7\/32.1-162.4","metadata":{"court_decisions":""}},{"id":359167,"structure_id":51372,"section_number":"32.1-162.5","catch_line":"Regulations","url":"\/32.1-162.5\/","token":"32.1\/5\/7\/32.1-162.5","metadata":{"court_decisions":""}},{"id":359168,"structure_id":51372,"section_number":"32.1-162.5:1","catch_line":"Notice to dispenser of patient's death; disposition of dispensed drugs","url":"\/32.1-162.5_1\/","token":"32.1\/5\/7\/32.1-162.5_1","metadata":false},{"id":359169,"structure_id":51372,"section_number":"32.1-162.6","catch_line":"Revocation or suspension of license","url":"\/32.1-162.6\/","token":"32.1\/5\/7\/32.1-162.6","metadata":false},{"id":359170,"structure_id":51372,"section_number":"32.1-162.6:1","catch_line":"Possession or administration of cannabis oil","url":"\/32.1-162.6_1\/","token":"32.1\/5\/7\/32.1-162.6_1","metadata":false}],"previous_section":{"id":359167,"structure_id":51372,"section_number":"32.1-162.5","catch_line":"Regulations","url":"\/32.1-162.5\/","token":"32.1\/5\/7\/32.1-162.5","metadata":{"court_decisions":""}},"next_section":{"id":359169,"structure_id":51372,"section_number":"32.1-162.6","catch_line":"Revocation or suspension of license","url":"\/32.1-162.6\/","token":"32.1\/5\/7\/32.1-162.6","metadata":false},"metadata":false,"official_url":"https:\/\/law.lis.virginia.gov\/vacode\/32.1-162.5:1\/","history_text":"

This law was first created in 2015. The record of its establishment is cataloged in chapter 668<\/a> of that year\u2019s edition of \u201cActs of Assembly,\u201d the annual state publication listing all changes made to the Code of Virginia in that year. It has been modified 2 times. Those modifications are cataloged by \u201cThe Acts of Assembly,\u201d a state publication, by year and chapter. Those modifications that can be read on the General Assembly\u2019s website will be linked accordingly. Those modifications are as follows: in 2018, chapter 95<\/a>; in 2020, chapter 739<\/a>.<\/p>","references":false,"refers_to":[{"id":359150,"section_number":"32.1-162.2","catch_line":"Exemptions from article","order_by":null,"url":"\/32.1-162.2\/"},{"id":368703,"section_number":"54.1-3411.2","catch_line":"Prescription drug disposal programs","order_by":null,"url":"\/54.1-3411.2\/"}],"permalink":{"id":1430287,"object_type":"law","relational_id":359168,"identifier":"32.1-162.5:1","token":"32.1\/5\/7\/32.1-162.5_1","url":"\/32.1-162.5_1\/","edition_id":2,"permalink":0,"preferred":1},"url":"\/32.1-162.5_1\/","token":"32.1\/5\/7\/32.1-162.5_1","dublin_core":{"Title":"Notice to dispenser of patient’s death; disposition of dispensed drugs","Type":"Text","Format":"text\/html","Identifier":"\u00a7 32.1-162.5:1","Relation":"Code of Virginia"},"html":"\n\t\t\t\t\t\t

A.<\/span> Any hospice licensed by the Department<\/span> or exempt from licensure pursuant to § 32.1-162.2<\/a> with a hospice patient<\/span> residing at home at the time of death shall notify every pharmacy that has dispensed partial quantities of a Schedule II controlled substance for a patient with a medical diagnosis documenting a terminal illness, as authorized by federal law<\/span>, within 48 hours of the patient’s death. <\/i><\/a><\/p><\/section>\n\t\t\t\t\t\t

B.<\/span> Any hospice licensed by the Department<\/span> or exempt from licensure pursuant to § 32.1-162.2<\/a> shall develop policies and procedures for the disposal of drugs, including opioids, dispensed as part of the hospice plan of care in accordance with the provisions of § 54.1-3411.2<\/a>. <\/i><\/a><\/p><\/section>","plain_text":" CODE OF VIRGINIA\n\nNOTICE TO DISPENSER OF PATIENT’S DEATH; DISPOSITION OF DISPENSED DRUGS (\u00a7\n32.1-162.5:1)\n\nA. Any hospice licensed by the Department or exempt from licensure pursuant to\n§ 32.1-162.2 with a hospice patient residing at home at the time of death\nshall notify every pharmacy that has dispensed partial quantities of a Schedule\nII controlled substance for a patient with a medical diagnosis documenting a\nterminal illness, as authorized by federal law, within 48 hours of the\npatient’s death.\n\nB. Any hospice licensed by the Department or exempt from licensure pursuant to\n§ 32.1-162.2 shall develop policies and procedures for the disposal of\ndrugs, including opioids, dispensed as part of the hospice plan of care in\naccordance with the provisions of § 54.1-3411.2.\n\nHISTORY: 2015, c. 668; 2018, c. 95; 2020, c. 739.","edition":{"id":2,"name":"2026","slug":"2026","date_created":"2026-07-16 18:40:23","date_modified":"2026-08-02 15:14:36","current":1,"order_by":2,"last_import":"2026-08-02 12:37:30"}}